24-HOUR MH HOTLINE

800-644-9737

FOR EMERGENCIES ONLY

 

MHAUS Blog

MH Readiness Feedback from Multiple Facilities

by Dianne Daugherty, MHAUS Executive Director

Monday, April 17, 2017 /

Tagged: General ·

The only requirement the Malignant Hyperthermia Association of the United States (MHAUS) will not waiver on is this:  Any facility using a trigger for malignant hyperthermia (potent volatile anesthetics and/or succinylcholine) must assure there is a sufficient supply of dantrolene sodium for injection available within 10 minutes, in whatever form …

0 Comments · 656 words · est. read time: 3 minutes · Read and Comment »

Long-term Sequelae In Patients Who Experienced a Malignant Hyperthermia Event

by MHAUS Staff

Tuesday, December 13, 2016 /

Tagged: For Patients ·

Werneid K, Riazi S, Brandom BW. Presented to the International Anesthesia Research Society (IARS) 2015 In the article Survey of Long-Term Sequelae in Survivors of a Malignant Hyperthermia Reaction, 23 people responded to a survey asking about the symptoms they experienced after an MH event. The most commonly reported symptoms …

4 Comments · 136 words · est. read time: 1 minute · Read and Comment »

Unexpected MH Deaths Without Exposure To Inhalation Anesthetics In Pediatric Patients

by MHAUS Staff

Tuesday, December 13, 2016 /

Tagged: For Patients ·

Brandom, BW, & Muldoon, SM. Paediatric Anaesthesia . September 2013. It is well documented that infants, children and adolescents with certain gene mutations are susceptible to malignant hyperthermia when exposed to certain medications including succinylcholine, a muscle relaxant, and inhalation anesthetics. However, fatal, MH-like episodes have also been documented in …

3 Comments · 213 words · est. read time: 1 minute · Read and Comment »

Temperature changes are not late signs of malignant hyperthermia: A NAMH Registry of MHAUS Study

by Guest Contributor

Tuesday, December 13, 2016 /

Tagged: For Patients ·

Temperature changes are not late signs of malignant hyperthermia: A NAMH Registry of MHAUS Study. Larach MG, Allen GC, Brandom BW, Gronert GA, & Lehman EB. Presented to the American Society of Anesthesiologists (ASA), 2008 Malignant hyperthermia poses a significant risk to affected patients. Despite modern treatment and increased availability …

1 Comment · 207 words · est. read time: 1 minute · Read and Comment »

Is there a link between malignant hyperthermia and exertional heat illness?

by Guest Contributor

Tuesday, December 13, 2016 /

Tagged: For Patients ·

Muldoon SM, Deuster P, Brandom BW, Bunger R. Exercise and Sport Sciences Reviews, 2004 It has been suggested that people who have experienced an episode of exertional heat illness may be more prone to malignant hyperthermia and vice versa due to a similar genetic mutation. Malignant hyperthermia (MH) is an …

0 Comments · 425 words · est. read time: 2 minutes · Read and Comment »

Intraoperative Presentation of MH Leads To KD Syndrome Diagnosis

by MHAUS Staff

Thursday, December 8, 2016 /

Tagged: General ·

Abstract: We present the novel case report of a child with hypotonia and dysmorphic features who developed malignant hyperthermia (MH) intraoperatively. Neurology workup revealed the presence of a known causative ryanodine receptor (RYR1) mutation for MH, c.7522C>T; p.R2508C. Furthermore, the neurology workup diagnosed the child with King-Denborough syndrome (KDS). This …

0 Comments · 126 words · est. read time: 1 minute · Read and Comment »

Long Term Oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual

by Guest Contributor

Thursday, November 17, 2016 /

Tagged: For Patients ·

Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients. Brandom, BW, & Muldoon, SM. Paediatric Anaesthesia. September 2013. It is well documented that infants, children and adolescents with certain gene mutations are susceptible to malignant hyperthermia when exposed to certain medications including succinylcholine, a muscle relaxant, and inhalation …

0 Comments · 1146 words · est. read time: 6 minutes · Read and Comment »

Honoring An MH Pioneer

by Guest Contributor

Tuesday, November 15, 2016 /

Tagged: General ·

Dr. Beverly Britt was a very significant contributor to important discoveries about malignant hyperthermia during her Professorship at the University of Toronto. Beverly was a dear friend of mine and was helpful to me as I started my career working with physicians; especially anesthesiologists.  Beverly died at her home in …

1 Comment · 570 words · est. read time: 3 minutes · Read and Comment »

CMS reported MH related deficiencies; are YOU ready?

by MHAUS Staff

Thursday, May 26, 2016 /

Tagged: General ·

From 2011 through 2015, CMS inspection findings at various health systems revealed "deficiencies" related to MH preparedness.  ARE YOU READY FOR MH?  Consider bringing one of MHAUS’ MH Experts to your facility to assure your plan of action is designed to address all areas of concern and you are appropriately …

0 Comments · 73 words · est. read time: 1 minute · Read and Comment »

ASPAN partners with MHAUS

by MHAUS Staff

Tuesday, May 10, 2016 /

Tagged: General ·

The American Society of PeriAnesthesia Nurses (ASPAN) has partnered with the Malignant Hyperthermia Association of the United States (MHAUS) to offer MHAUS membership benefits to active ASPAN members at a reduced rate. “For many years, ASPAN has supported and upheld the mission of MHAUS, and remains focused on assuring their …

0 Comments · 606 words · est. read time: 3 minutes · Read and Comment »


 

NEW!! Question about this page or topic?
If you've used the search function at the top of our pages and still haven't
found what you need, use our online form to ask for more information!